New data on aspirin and colorectal cancer brings calls for new guidelines, more research.

نویسنده

  • Caroline McNeil
چکیده

T hree large studies in the past 14 months have reopened a longstanding issue in colorectal cancer: Can aspirin prevent it? Or more precisely, is the evidence for preventive benefit in people at average risk strong enough to outweigh the known risks of regular aspirin use? Up to now, the committees that draw up cancer prevention guidelines have concluded that the evidence for aspirin ’ s benefi ts was insuffi cient when weighed against the risk of gastrointestinal bleeding, a common side effect that can be severe; aspirin can also cause hemorrhagic stroke. But the new studies, though not perfect, could tip the scales in favor of aspirin, say some experts. The accumulated data now “arguably support more general recommendations to consider aspirin for prevention of colorectal cancer in the context of individualized risk-benefi t assessments,” wrote Andrew Chan, M.D. Harvard Medical School, Boston, and Scott Lippman, M.D. at the M.D. Anderson Cancer Center in Houston, in their Lancet editorial on December 17 th . “We ’ re in a situation where no single study will settle all the questions for everyone,” Chan said in an interview. “But a lot of evidence is in and we’ve reached a point where there is a suffi cient body of evidence for us to no longer question if aspirin can prevent colorectal cancer, but to decide what kind of risk stratifi cation we need.” Others argue that the evidence is still not strong enough, pointing to weaknesses in the new studies. Nevertheless, it seems certain that guideline committees will revisit the issue in 2012 and that ongoing research on aspirin ’ s risks and benefi ts in cancer prevention has taken on new visibility.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Antiproliferative Effect of Aspirin on Colorectal Cancer Cell Line

Background: Nonsteroidal anti-inflammatory drugs (NSAIDs) such as Aspirin may have anticancer properties, and can be effective as a novel strategy for the treatment of colorectal cancer (CRC). The aim of this study was to assess the cytotoxic effects of Aspirin drug in CRC cell lines compared with Oxaliplatin drug in vitro. Methods: Cell viability was assessed after treatment of SW742 and SW48...

متن کامل

New Approaches to Use Nanoparticles for Treatment of Colorectal Cancer; a Brief Review

Nanoparticles have been at the center of research focus as a new promising material for the treatment of cancer in recent years. Although many chemotherapy drugs for cancer treatment are available, their potential toxicity is the main point of concern. On the other hand, the conventional chemotherapeutic approach has not been found to be very efficient in colorectal cancer (CRC) as the drug mol...

متن کامل

A review on miRNAs as new biomarkers for colorectal cancer

Background & Objective: Since colorectal cancer does not often have phenotypic symptoms in the early stages, the study of biomarkers for the diagnosis and prognosis of the tumor is very important. MicroRNAs are one of the most important biomarkers which attract the attention of many researchers due to a variety of reasons, including their non-invasive nature; these molecules are a group of non-...

متن کامل

Exploring the spatial patterns of three prevalent cancer latent risk factors in Iran; Using a shared component model

Background and aims: The aim of this study was the modeling of the incidence rates of Colorectal, breast and prostate cancers using a shared component model in order to explore the spatial pattern of their shared risk factors (i.e., obesity and low physical activity) affecting on cancer incidence, and also to estimate the relative weight of these shared components. Methods: In this study,...

متن کامل

شاخص های اپیدمیولوژیک و کلینیکو پاتولوژیک سرطانهای کولورکتال در ساری 1386-1378

Background and Purpose: Each year, about 50,000 new cases of cancer occur in Iran and the most common being the gastrointestinal (GI) tract (38%). Colorectal cancers account for the 3rd and 4th most prevalent cancers in Iranian men and women, respectively. Since genetic and environmental factors lead to differences in colorectal cancer occurrence in different geographic regions and races, we ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Journal of the National Cancer Institute

دوره 104 3  شماره 

صفحات  -

تاریخ انتشار 2012